Table I.
Patient’s disease, pretreatment, and donor characteristics.
| Characteristics | Number |
|---|---|
| Initial disease | |
| acute myeloblastic leukemia (AML) | 5 |
| chronic lymphoïd leukemia (CLL) | 2 |
| non hodgkin lymphoma (NHL) | 2 |
| hodgkin disease | 1 |
| myelodisplasia | 2 |
| chronic myeloid leukemia (CML) | 1 |
| acute lymphoblastic leukemia (ALL) | 1 |
| multiple myeloma | 1 |
| myeloid splenomegaly | 1 |
| solid tumors | 5 |
| Transplantation | |
| first | 17 |
| second | 4 |
| Type | |
| peripheral blood stem cell | 15 |
| bone marrow | 6 |
| Status after | |
| complete remission | 8 |
| partial response | 6 |
| stable disease | 0 |
| relapse | 1 |
| progressive disease | 5 |
| chronic phase | 1 |
| Conditionning regimen | |
| non myeloablative | 13 |
| myeloablative | 8 |
| Acute GVHD prophylaxis | |
| Cyclosporine | |
| yes | 20 |
| no | 1 |
| Methotrexate | |
| yes | 8 |
| no | 13 |
| Steroids | |
| yes | 0 |
| no | 21 |
| Other drug | |
| yes | 10 |
| no | 11 |
| Donor and recipient compatibility | |
| Gender | |
| yes | 10 |
| no | 11 |
| ABO | |
| yes | 9 |
| minor incompatibility | 7 |
| major incompatibility | 5 |
| Histocompatibility (HLA) | |
| matched sibling donor | 17 |
| matched unrelated donor | 2 |
| mismatched unrelated donor | 2 |